Intuitive Surgical: Great Company, But Looking Overpriced
Summary
- Intuitive Surgical is a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery.
- I saw a 21% increase in sales for their flagship da Vinci procedures robot, which the company expects to continue.
- Revenue increased 17% to $1.9bn vs 2022 Q4, with a solid and stable gross margin of 66%.
- But it has a very high P/E and EV/EBITDA, and there are a few factors that make it look overpriced.
Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.